Anocca

Sodertalje, Sweden · Founded 2014 · Privately Held (backing)

Developer of drugs and immunotherapies intended to unlock the therapeutic potential of T-cell immunity. Anocca is based in Sodertalje, Sweden and was founded in 2014. Its last reported valuation was $110 million in May 2023. It has raised $211 million.

Last reported valuation
$110.2M
Oct 2026
Priced at
—
Total raised
$210.6M
Last round
—

Who backs Anocca?

9 investors
InvestorType
European UnionOther
NidocoOther
Ramsbury InvestFamily office
AMF—
Harald Mix—
Mellby Gård—
Michano—
Robert Andreen—
Swedbank Robur—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Anocca investors

9 investors are on record for Anocca, including European Union, Nidoco, Ramsbury Invest and AMF.

Free account
More of Anocca with a free account
  • ·Watch Anocca: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Anocca. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View